NCT05956652 is a clinical trial of Hydra Transcatheter Aortic Valve System in Aortic Valve Stenosis, sponsored by Sahajanand Medical Technologies Limited.

Who is sponsoring NCT05956652?

NCT05956652 is sponsored by Sahajanand Medical Technologies Limited.

What drugs are being tested in NCT05956652?

Interventions in NCT05956652: Hydra Transcatheter Aortic Valve System.

What condition does NCT05956652 study?

NCT05956652 studies Aortic Valve Stenosis.

Is NCT05956652 still recruiting?

NCT05956652 is currently recruiting now. Last updated 16 May 2025.

Last reviewed 2025-05-16 · How we verify

NCT05956652

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hydra Registry - Italy Experience

Recruiting now Last updated 16 May 2025

What this trial tests

trial testing Hydra Transcatheter Aortic Valve System in Aortic Valve Stenosis in 500 participants. Currently enrolling.

Timeline

1 July 2023

Primary endpoint
31 July 2025

31 July 2029

Quick facts

Lead sponsor	Sahajanand Medical Technologies Limited
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 July 2023
Primary completion	31 July 2025
Estimated completion	31 July 2029
Sites	4 locations across Italy

Drugs / interventions tested

Hydra Transcatheter Aortic Valve System

Conditions studied

Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →

Sponsor

Sahajanand Medical Technologies Limited — full company profile →

Who can join

Adults 18 to 99, any sex, with Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hydra-IT is a multicenter observational study aim to collect clinical, procedural and follow-up data and evaluate the short, medium and long term results of Hydra TAVI System in patient with severe aortic stenosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Valve Stenosis

Currently open trials in the same condition.

NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
NCT07520656 — Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing · recruiting
NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting

Other Sahajanand Medical Technologies Limited trials

Trials by the same sponsor.

NCT06507579 — Hydra Registry - UK · recruiting
NCT06342635 — Hydra Single-centre Experience - Copenhagen, Denmark · recruiting
NCT04138238 — Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05956652 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sahajanand Medical Technologies Limited
Last refreshed: 16 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05956652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing